CLINICAL TRIALS PROFILE FOR OFLOXACIN
✉ Email this page to a colleague
All Clinical Trials for ofloxacin
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00002249 ↗ | A Double-Blind Study to Evaluate the Safety and Pharmacokinetics of L-Ofloxacin (RWJ 25213) in Subjects With HIV Infection | Completed | R W Johnson Pharmaceutical Research Institute | Phase 1 | 1969-12-31 | To determine the safety and pharmacokinetics of L-ofloxacin (RWJ 25213) in patients with HIV infection. |
NCT00002850 ↗ | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy | Completed | Eastern Cooperative Oncology Group | Phase 3 | 1997-03-01 | RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma. |
NCT00002850 ↗ | Antibiotic Therapy in Preventing Early Infection in Patients With Multiple Myeloma Who Are Receiving Chemotherapy | Completed | National Cancer Institute (NCI) | Phase 3 | 1997-03-01 | RATIONALE: Giving antibiotics may be effective in preventing or controlling early infection in patients with multiple myeloma and may improve their response to chemotherapy. PURPOSE: This randomized clinical trial is studying antibiotics to see how well they work compared to no antibiotics in preventing early infection in patients with multiple myeloma. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ofloxacin
Condition Name
Clinical Trial Locations for ofloxacin
Trials by Country
Clinical Trial Progress for ofloxacin
Clinical Trial Phase
Clinical Trial Sponsors for ofloxacin
Sponsor Name